Stories Tagged as
Drugs
Why do pharmaceutical companies give away some expensive drugs for free?
by
Janet Nguyen
Mar 31, 2023
Some offer patient assistance programs, where people can access drugs for free, or cheaper than they would normally pay.
A $30 million gift to build an addiction treatment center. Then staffers had to run it.
Jan 19, 2023
The money was a one-time gift for infrastructure, but to stay running, the clinic is on its own.
Researchers say they have first evidence of a drug that can improve COVID-19 survival
by
Michelle Roberts
and Alex Schroeder
Jun 16, 2020
U.K. researchers say the cheap, widely available steroid dexamethasone reduced deaths by up to one-third in severely ill hospitalized patients.
The U.S. wants El Chapo to pay nearly $12.7B as part of his sentence
by
Andy Uhler
Jul 16, 2019
Coming up with the number is one thing. Seizing that cash, experts agree, is another matter entirely.
A last-minute ruling means TV ads won't list drug prices as planned
Jul 9, 2019
Some experts doubt that the rule would have been capable of lowering drug prices.
From cringeworthy to scary: a history of anti-drug PSAs
Mar 26, 2019
We remember anti-drug PSAs for reasons their makers didn't intend.
For public good, not for profit.
FDA approves new Johnson & Johnson drug for depression
by
Renata Sago
Mar 6, 2019
The Food and Drug Administration has approved the first new kind of drug to treat depression since Prozac hit the scene in the late 1980s. Spravato is a nasal spray from Johnson & Johnson that’s a close cousin of ketamine, an anesthetic that’s sometimes used recreationally and often known as “Special K.” Because ketamine can cause […]
The Sinaloa Cartel sans El Chapo
Feb 12, 2019
Is losing the leader of a drug-trafficking organization bad for business?
Big Pharma is betting big on cancer drugs
Jan 3, 2019
Bristol-Myers Squibb announced Thursday that it’s going to acquire another drugmaker, Celgene. The deal is worth about $74 billion. The combined company will have nine products with sales of more than a billion dollars a year, including some blockbuster cancer drugs. The merger is a sign that Big Pharma is betting big on cancer medications. […]